author-photo

Jin-Liern Hong

Takeda Pharmaceutical Company

3

Papers

1

Citations

Citation Trend

Filter By

Papers (3) Sort By

Journal Conference Others

Real-world response and outcomes in NSCLC patients with EGFR exon 20 insertion mutations.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Comparing Bortezomib-Lenalidomide-Dexamethasone (VRd) with Carfilzomib-Lenalidomide-Dexamethasone (KRd) in the Patients with Newly Diagnosed Multiple Myeloma (NDMM) in Two Observational Studies

2018 Blood
Show All
- Source
- Cite
- Save
Citations (1)
Dynamic Changes in International Staging System As a Predictor of Survival Outcome in Patients with Advanced Multiple Myeloma

2018 Blood
Show All
- Source
- Cite
- Save
Citations (0)